Entero Therapeutics Inc. (ENTO)
NASDAQ: ENTO
· Real-Time Price · USD
2.75
0.45 (19.57%)
At close: Sep 12, 2025, 12:01 PM
Entero Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | 35.6K | 12.29K | 7.32K | 23.41K | 23.13K | 22.85K | 22.57K | 22.29K | 30.82K | 30.5K | 132.35K | 138K | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | -35.6K | -12.29K | -7.32K | -23.41K | -23.13K | -22.85K | -22.57K | -22.29K | -30.82K | -30.5K | -132.35K | -138K | n/a | n/a |
Operating Income | -638.86K | -821.39K | -1.2M | -1.89M | -3.43M | -9.23M | -4.09M | -3.43M | -4.18M | -4.06M | -2.28K | 4.39K | -5.41K | -9.38K | -8.81K | -30.4K | -9.28K | -8.21K |
Interest Income | n/a | n/a | n/a | n/a | 218.00 | 228.00 | 224.00 | 229.00 | 205.00 | 1.87K | 4.69K | 2.66K | 926.00 | 139.00 | 1.17K | 0.74 | 2.95 | 403.00 |
Pretax Income | -674.93K | -948.11K | -1.19M | -1.9M | -3.43M | -9.29M | -4.1M | -3.43M | -4.19M | -4.07M | -3.99K | 4.39K | -5.41K | -9.63K | -11.17K | -30.4K | -9.28K | -7.69K |
Net Income | -998.27K | -1.26M | -12.24M | -2.58M | -8.81M | 5.57M | -4.1M | -3.43M | -4.19M | -4.07M | -3.99M | 4.39M | -5.41M | -9.63M | -11.17M | -30.4M | -9.28M | -7.69M |
Selling & General & Admin | 628.23K | 805.56K | 1.18M | 1.69M | 3.17M | 8.66M | 2.79M | 2.42M | 2.83M | 2.7M | 2.18K | 2.9K | 2.5K | 4.41K | 3.04K | 6.02K | 3.63K | 5.7K |
Research & Development | 10.63K | 15.83K | 21.42K | 207K | 219.59K | 565.96K | 1.31M | 1.01M | 1.35M | 1.36M | 101.82 | 7.29K | 2.91K | 4.98K | 5.78K | 24.38K | 5.65K | 2.52K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | -653 | -495 | n/a | -2.62K | -1.11K | 6.56K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 638.86K | 821.39K | 1.2M | 1.89M | 3.39M | 9.23M | 4.09M | 3.43M | 4.18M | 4.06M | 3.98K | 4.39K | 5.41K | 9.62K | 11.17K | 30.4K | 9.28K | 7.68K |
Interest Expense | 36.07K | 17.9K | n/a | n/a | n/a | 66.2K | 7.05K | 1.25K | 5.18K | 8.99K | 6.19K | 863.00 | 3.22K | 5.61K | 2.4K | 742.00 | 2.95K | 5.14K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -35.6K | n/a | n/a | n/a | n/a | n/a | -115 | 36.00 | 50.00 | 28.00 | -186 | 79.00 | 57.00 | 52.00 |
Cost & Expenses | 638.86K | 821.39K | 1.2M | 1.89M | 3.43M | 9.23M | 4.09M | 3.43M | 4.18M | 4.06M | 3.98K | 4.39K | 5.41K | 9.62K | 11.17K | 30.4K | 9.28K | 7.68K |
Income Tax Expense | n/a | n/a | 10.6M | n/a | 4.26M | -14.86M | n/a | n/a | n/a | n/a | -1.7M | 157.58 | 144.43 | 685.79 | 116.23 | 118.09 | 3.45K | 22.3K |
Shares Outstanding (Basic) | 4.77M | 4.77M | 4.75M | 4.55M | 2.29M | 1.76M | 357.32K | 378.3K | 113.55K | 114.03K | 49.75K | 11.44K | 5.19K | 3.7K | 3.54K | 2.22K | 1.86K | 1.32K |
Shares Outstanding (Diluted) | 4.77M | 4.77M | 4.75M | 4.55M | 2.29M | 1.32M | 357.32K | 378.3K | 113.55K | 114.03K | 49.75K | 11.61K | 5.19K | 3.7K | 3.54K | 2.22K | 1.86K | 1.32K |
EPS (Basic) | -0.21 | -0.28 | -2.57 | -0.57 | -3.84 | 3.12 | -11.48 | -9.08 | -36.89 | -35.7 | -80.12 | 370.12 | -1.04K | -2.6K | -3.16K | -13.67K | -4.99K | -5.83K |
EPS (Diluted) | -0.21 | -0.28 | -2.57 | -0.57 | -3.84 | 4.23 | -11.48 | -9.08 | -36.89 | -35.7 | -80.12 | 364.59 | -1.04K | -2.6K | -3.16K | -13.67K | -4.99K | -5.83K |
EBITDA | -638.86K | -930.2K | -1.2M | -1.89M | -3.39M | -9.21M | -4.09M | -3.43M | -4.17M | -4.06M | -3.96M | 4.41M | -5.4M | -9.59M | -11.04M | -30.26M | -9.14M | -7.55M |
EBIT | -638.86K | -930.2K | -1.2M | -1.89M | -3.43M | -9.23M | -4.09M | -3.43M | -4.18M | -4.06M | -3.98M | 4.39M | -5.4M | -9.62M | -11.17M | -30.4M | -9.28M | -7.68M |
Depreciation & Amortization | n/a | n/a | n/a | 1.34K | 35.32K | 12.29K | 7.32K | 7.32K | 7.32K | 7.32K | 7.32 | 7.32 | 7.32 | 7.32 | 137.20 | 138.26 | 133.88 | 132.91 |